Literature DB >> 4147967

Further evidence for the heterogeneous storage of noradrenaline in central noradrenergic terminals.

A M Thierry, G Blanc, J Glowinski.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4147967     DOI： 10.1007/bf00500605

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN： 0028-1298            Impact factor:   3.000


× No keyword cloud information.
  24 in total

1.  EFFECT OF DRUGS ON THE UPTAKE, RELEASE, AND METABOLISM OF H3-NOREPINEPHRINE IN THE RAT BRAIN.

Authors:  J GLOWINSKI; J AXELROD
Journal:  J Pharmacol Exp Ther       Date:  1965-07       Impact factor: 4.030

2.  Disposition and role of newly synthesized amines in central catecholaminergic neurons.

Authors:  J Glowinski; M J Besson; A Cheramy; A M Thierry
Journal:  Adv Biochem Psychopharmacol       Date:  1972

3.  Disposition of newly synthesized amines in cell bodies and terminals of central catechol aminergic neurons. I. Effect of amphetamine and thiorproperazine on the metabolism of CA in the caudate nucleus, the substantia nigra and the ventromedial nucleus of the hypothalamus.

Authors:  F Javoy; M Hamon; J Glowinski
Journal:  Eur J Pharmacol       Date:  1970-05       Impact factor: 4.432

4.  Some problems encountered in attempting to estimate catecholamine turnover using lbbelled tyrosine.

Authors:  T Persson; B Waldeck
Journal:  J Pharm Pharmacol       Date:  1970-07       Impact factor: 3.765

5.  Dopamine-norepinephrine: another regulatory step of norepinephrine synthesis in central noradrenergic neurons.

Authors:  A M Thierry; G Blanc; J Glowinski
Journal:  Eur J Pharmacol       Date:  1971-05       Impact factor: 4.432

6.  Storage and synthesis of norepinephrine in the reserpine-treated rat brain.

Authors:  J Glowinski; L L Iversen; J Axelrod
Journal:  J Pharmacol Exp Ther       Date:  1966-03       Impact factor: 4.030

7.  Stereotaxic mapping of the monoamine pathways in the rat brain.

Authors:  U Ungerstedt
Journal:  Acta Physiol Scand Suppl       Date:  1971

8.  On the significance of central noradrenaline for motor activity: experiments with a new dopamine beta-hydroxylase inhibitor.

Authors:  T H Svensson; B Waldeck
Journal:  Eur J Pharmacol       Date:  1969-09       Impact factor: 4.432

9.  Distribution of noradrenaline nerve terminals in cortical areas of the rat.

Authors:  K Fuxe; B Hamberger; T Hökfelt
Journal:  Brain Res       Date:  1968-04       Impact factor: 3.252

10.  The effects of pentobarbital on the fate of intracisternally administered norepinephrine-H3.

Authors:  S M Schanberg; J J Schildkraut; I J Kopin
Journal:  J Pharmacol Exp Ther       Date:  1967-08       Impact factor: 4.030
View more
  5 in total

Review 1.  The functional pool of brain catecholamines: its size and turnover rate.

Authors:  R Papeschi
Journal:  Psychopharmacology (Berl)       Date:  1977-11-24       Impact factor: 4.530

2.  Noradrenergic innervation of the median eminence. Microspectrofluorimetric and pharmacological study in the duck, Anas platyrhynchos.

Authors:  A Calas; H G Hartwig; J P Collin
Journal:  Z Zellforsch Mikrosk Anat       Date:  1974-03-21

3.  Studies on the nature of the releasable pool of dopamine in synaptosomes from rat corpus striatum: depolarization-induced release of 3H-dopamine from superfused synaptosomes labelled under various conditions.

Authors:  C D de Langen; J C Stoof; A H Mulder
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-07       Impact factor: 3.000

4.  Kinetic characteristics of newly synthesized 3H-5-HT in the brain of control and reserpinized mice. Evidence for the heterogeneous distribution of 5-HT in serotoninergic neurons.

Authors:  Y Morot-Gaudry; S Bourgoin; M Hamon
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-07       Impact factor: 3.000

5.  Noradrenergic neurotransmission in the brain of a convulsive mutant mouse, differences between the cerebral cortex and the brain stem.

Authors:  Y Maurin; S Arbilla; J Dedek; C R Lee; N Baumann; S Z Langer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-07       Impact factor: 3.000
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.